Literature DB >> 20514064

Meningococcal group A, C, Y and W-135 conjugate vaccine.

Lee H Harrison1, Nitin Mohan, Peter Kirkpatrick.   

Abstract

In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people aged 11-55 years.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20514064     DOI： 10.1038/nrd3194

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  12 in total

1.  A universal vaccine for serogroup B meningococcus.

Authors:  Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; Beatrice Aricò; Silvana Savino; Laura Santini; Brunella Brunelli; Stefania Bambini; Alessia Biolchi; Barbara Capecchi; Elena Cartocci; Laura Ciucchi; Federica Di Marcello; Francesca Ferlicca; Barbara Galli; Enrico Luzzi; Vega Masignani; Davide Serruto; Daniele Veggi; Mario Contorni; Maurizio Morandi; Alessandro Bartalesi; Vanda Cinotti; Donatella Mannucci; Francesca Titta; Elisa Ovidi; Jo Anne Welsch; Dan Granoff; Rino Rappuoli; Mariagrazia Pizza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-06       Impact factor: 11.205

Review 2.  Global epidemiology of meningococcal disease.

Authors:  Lee H Harrison; Caroline L Trotter; Mary E Ramsay
Journal:  Vaccine       Date:  2009-05-27       Impact factor: 3.641

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.

Authors:  A Arguedas; C Soley; C Loaiza; G Rincon; S Guevara; A Perez; W Porras; O Alvarado; L Aguilar; A Abdelnour; U Grunwald; L Bedell; A Anemona; P M Dull
Journal:  Vaccine       Date:  2010-02-26       Impact factor: 3.641

5.  A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.

Authors:  Terry Nolan; Stephen Lambert; Don Roberton; Helen Marshall; Peter Richmond; Catherine Streeton; Jan Poolman; Dominique Boutriau
Journal:  Vaccine       Date:  2007-10-25       Impact factor: 3.641

6.  Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.

Authors:  Amanda C Cohn; Jessica R MacNeil; Lee H Harrison; Cynthia Hatcher; Jordan Theodore; Mark Schmidt; Tracy Pondo; Kathryn E Arnold; Joan Baumbach; Nancy Bennett; Allen S Craig; Monica Farley; Ken Gershman; Susan Petit; Ruth Lynfield; Arthur Reingold; William Schaffner; Kathleen A Shutt; Elizabeth R Zell; Leonard W Mayer; Thomas Clark; David Stephens; Nancy E Messonnier
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

Review 7.  Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages.

Authors:  Michael Bröker; Peter M Dull; Rino Rappuoli; Paolo Costantino
Journal:  Vaccine       Date:  2009-07-18       Impact factor: 3.641

8.  Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.

Authors:  Che-Hung Lee; Wen-Chun Kuo; Suresh Beri; Subash Kapre; Jayant S Joshi; Nancy Bouveret; F Marc LaForce; Carl E Frasch
Journal:  Vaccine       Date:  2008-12-06       Impact factor: 3.641

9.  Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

Authors:  Matthew D Snape; Kirsten P Perrett; Karen J Ford; Tessa M John; David Pace; Ly-Mee Yu; Joanne M Langley; Shelley McNeil; Peter M Dull; Francesca Ceddia; Alessandra Anemona; Scott A Halperin; Simon Dobson; Andrew J Pollard
Journal:  JAMA       Date:  2008-01-09       Impact factor: 56.272

10.  Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.

Authors:  Leah D Fletcher; Liesel Bernfield; Vicki Barniak; John E Farley; Alan Howell; Melissa Knauf; Peggy Ooi; Robert P Smith; Paige Weise; Mike Wetherell; Xiaoling Xie; Robert Zagursky; Ying Zhang; Gary W Zlotnick
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441
View more
  7 in total

1.  Improvement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development.

Authors:  Noëlle Mistretta; Bruno Guy; Yves Bérard; François Dalençon; Olivia Fratantonio; Christophe Grégoire; Aurélie Lechevallier; Philippe Lhéritier; Laurent Revet; Monique Moreau; Jean Haensler; Bachra Rokbi
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

2.  Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Zhongwu Guo
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

3.  Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.

Authors:  Rolando Pajon; Andrew M Fergus; Dan M Granoff
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

4.  Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis.

Authors:  Guochao Liao; Zhifang Zhou; Sharad Suryawanshi; Mohabul A Mondal; Zhongwu Guo
Journal:  ACS Cent Sci       Date:  2016-04-04       Impact factor: 14.553

5.  Carrier Proteins Facilitate the Generation of Antipolysaccharide Immunity via Multiple Mechanisms.

Authors:  Ying-Jie Lu; Richard Malley; Fan Zhang; Claudette Thompson; Nicole Ma
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

6.  Meningococcal disease: changes in epidemiology and prevention.

Authors:  Qiuzhi Chang; Yih-Ling Tzeng; David S Stephens
Journal:  Clin Epidemiol       Date:  2012-09-19       Impact factor: 4.790

7.  Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection.

Authors:  Majela González-Miró; Laura M Rodríguez-Noda; Mildrey Fariñas-Medina; Barbara Cedré-Marrero; Sandra Madariaga-Zarza; Caridad Zayas-Vignier; Mabel Hernández-Cedeño; Torsten Kleffmann; Dagmar García-Rivera; Vicente Vérez-Bencomo; Bernd H A Rehm
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.